About Veravas

Veravas is a laboratory diagnostic company with a patient sample transformation technology, VeraBIND (Biomarker Isolation and N-richment for Detection) dedicated to making early detection of disease related biomarkers possible in challenging sample types.  VeraBIND starts with any complex sample (saliva, blood, urine, and stool) and uses the company’s proprietary magnetic beads to purify and concentrate biomarkers of interest to create a new matrix-free sample.  Detection of biomarkers free of the sample matrix allows for rapid development of highly accurate assays to detect low-abundance biomarkers by any detection methodology.

Veravas’ products are designed with convenience, sensitivity, accuracy, and cost-effectiveness in mind, allowing researchers, lab directors, commercial test manufacturers, and Veravas themselves to develop highly sensitive assays for early detection of disease, clinical trials, precision diagnosis, and treatment monitoring.

Scientific Advisory Board

  • Hidde Ploegh, PhD

    Chairman

    Dr. Ploegh is an immunologist at Boston Children's Hospital, known for his contributions in understanding antigen processing and the evasion of the immune system by viruses. Ploegh’s Whitehead Institute lab, which he established in 2005, has focused on developing innovative tools and techniques with which to explore the complexities of the immune system and its response to antigens, including those from invading pathogens and cancer cells. Prior to joining Whitehead, Ploegh taught at Harvard Medical School, where he led the immunology program. Before moving to Harvard, Ploegh was a Professor of Biology at MIT’s Center for Cancer Research (now the David H. Koch Institute for Integrative Cancer Research). Ploegh’s honors include a Meritorious Career Award from the American Association of Immunologists, and a special National Institutes of Health Director's Pioneer Award in support of “high-risk, high-reward” research. He is also a member National Academy of Sciences.​

    ​​

  • Armin Alaedini, PhD

    Scientific Advisor

    Professor at Columbia University & New York Medical College; member of Neurobiology of Pain study section at NIH. Dr. Alaedini has extensive experience as a principal investigator in academia and senior manager in industry, with over 20 years of research focused on host-microbe interaction, inflammation, and biomarker discovery in the context of autoimmunity, infectious disease, and complex spectrum disorders. An internationally recognized expert in the areas of celiac disease, gluten sensitivity, and Lyme disease research.​​

  • Michael Dougan, MD, PhD

    Scientific Advisor

    Dr. Dougan is an Assistant Professor of Medicine at Harvard Medical School and an assistant physician in the Department of Medicine, Division of Gastroenterology at Massachusetts General Hospital. Dr. Dougan has focused his research efforts on understanding the immune mechanisms underlying the mucosal inflammatory toxicities resulting from cancer immunotherapy. Dr. Dougan received his MD and PhD from Harvard Medical School.​​

Careers

Do you have the skills and the passion to move diagnostics and precision medicine forward? Learn more about career opportunities at Veravas.